Strattera, generically known as atomoxetine, is a non-stimulant drug that treats adults and children with attention-deficit hyperactivity disorder (ADHD). It is the first non-stimulant approved by the U.S. Food and Drug Administration (FDA) to treat ADHD. Strattera and all other non-stimulants are typically thought to be less effective at treating. [...]